| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.01 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.01 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |